HCV
Hepatitis C virus(HCV) is an enveloped, single-stranded RNA virus, belonging to the Flaviviridae family. HCV infection is a major cause of chronic hepatitis worldwide, leading to steatosis, liver cirrhosis and hepatocellular carcinoma. Significant advances in understanding the mechanism of HCV infection have been made since the development of a cell system reproducing the complete HCV cell cycle in vitro. HCV represents a new paradigm in interactions between the virus and its target cell, the human hepatocyte, due to the centralrole of lipoproteins in the HCV life cycle. HCV cell entry is a multi-step process: heparan sulphate and/or low-density lipoprotein receptor are cell surface factors mediating an initial virus attachment; subsequent virus interaction with tetraspanin CD81 and the human scavenger receptor SR-BI, the main HCV receptors, tiggers virus movement to the tight junctions and its uptake via Claudin-1 and occluding.
References
1.Budkowska A. Pol J Microbiol. 2009;58(2):93–98.
References
1.Budkowska A. Pol J Microbiol. 2009;58(2):93–98.
Microbiology/Virology
HCV
-
HCV-IN-4
catalog no : M30167
cas no: 2058080-25-2
HCV-IN-4 is a potent and orally active HCV NS5A inhibitor, shows great potency against GT1a, GT2b, GT3a, GT1a Y93H and GT1a L31V, with EC90s of 3 pM, 0.3 nM, 0.01 nM, 0.5 nM and 0.02 nM, respectively. -
Chlorcyclizine
catalog no : M28856
cas no: 82-93-9
CHLORCYCLIZINE is a histamine H1 antagonist and a potent hepatitis C virus (HCV) entry inhibitor. -
SB-734117
catalog no : M28776
cas no: 607368-97-8
SB-734117 inhibits productive replication of several HCMV strains. SB-734117 exhibited polypharmacology and was an inhibitor of several proteins from the AGC and CMCG kinase groups. -
HCV-IN-31
catalog no : M28773
cas no: 1998705-62-6
HCV-IN-31 is a HCV inhibitor with an EC50/EC95 of 15.7 μM. -
Samatasvir
catalog no : M28765
cas no: 1312547-19-5
Samatasvir is a pan-genotypic inhibitor of the HCV non-structural protein 5A.